Page 3 - Nppa

Covid-19: NPPA caps price of liquid medical oxygen, cylinders for 6 months

The present situation of Covid-19 has resulted in increased demand of medical oxygen up to almost four times from 750 MT per day to around 2,800 MT per day, the Ministry said

Regulator extends price cap on knee implants by one month till Sept 15

The NPPA had allowed firms to take a 10 per cent hike for their knee implant products last year

Drug price monitoring unit set up in Karnataka under aegis of NPPA

The government on Thursday said aprice monitoring and resource unit (PMRU) has been set up in Karnataka under the aegis of the National Pharmaceutical Pricing Authority (NPPA)

Top biz headlines: GoAir stops int'l ops, exporters seek govt aid, and more

From GoAir suspending international flights to digital payments getting the boost amidst Covid-19 concerns, Business standard brings to you the top headlines of the day

NPPA allows differential price for Meril's biodegradable cardiac stent

The National Pharmaceutical Pricing Authority (NPPA) invoked the para 32 (ii) of the Drug Price Control Order, 2013 to grant the exemption to the indigenously developed stent

Cipla, Glenmark get NPPA nod for inhaler pricing over 'innovative' quotient

Glenmark had appealed to the pricing regulator in 2016 asking for a differential price for its Digihaler

Price hike, at last

Govt should not control drug prices

Ceiling prices of 21 key medicines raised by 50%; NPPA invokes DPCO 2013

The prices of APIs have gone up in the range of 5-88%

Health care sector is on a recovery path after muted performance: Icra

The strong performance of the sector is in line with our expectations: Icra

Will not allow cost of knee implants to rise beyond 10% in a year: Govt

The NPPA notified the ceiling price of orthopaedic knee implants on 16th August, 2017

Drug pricing regulator recovers just 14% dues from pharma firms in 21 years

The NPPA website notes that the amount still under litigation is around Rs 4,084.05 crore

NPPA undermined

Govt decides to have bureaucracy set drug prices

By March 15, medical devices firms must submit price data: NPPA ultimatum

This is in order to monitor the price movement of 19 medical devices out of 23 medical devices notified as drugs under the Drugs and Cosmetics Acts

NPPA fixes retail prices of 14 formulations

The formulations with fixed retail prices include Telmisartan and Chlorthalidone Tablet used in treating high blood pressure marketed by Sun Pharma

NPPA caps prices of 39 drugs used for treating cancer, malaria

The steps are in continuation of the government's drive to make affordable quality medicines available to patients

Set up tribunal to hear firms' drug price appeals: NPPA

Setting up of an advisory committee has been a long-standing demand of the industry

NPPA fines health hub for overcharging on stents

On February 13, NPPA had capped the price of drug-eluting stents at Rs 29,600

NPPA fixes ceiling price of 30 more formulations

Total number of formulations under the price control since April 2016 has reached around 760

NPPA finalises format to monitor price of 19 medical devices

Currently, the government monitors the price movement of 19 medical devices

NPPA revises rates of 6 drugs, fixes price of 1 medicine

It has fixed the price of P-PPi-L capsules which are used for treating acidity